Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.

Johnson, David H

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jun 2004 - 2184-91 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial

0732-183X

10.1200/JCO.2004.11.022 doi


Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bevacizumab
Carboplatin--administration & dosage
Carcinoma, Non-Small-Cell Lung--drug therapy
Dose-Response Relationship, Drug
Female
Humans
Lung Neoplasms--drug therapy
Male
Paclitaxel--administration & dosage
Proportional Hazards Models
Survival Analysis